LEADER 01214nam  2200373Ia 450 
001 9910697097003321
005 20230902161642.0
035   $a(CKB)5470000002383927
035   $a(OCoLC)574939307
035   $a(EXLCZ)995470000002383927
100   $a20100326d1994      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aReviewer guidance$b[electronic resource] $evalidation of chromatographic methods
210  1$aRockville, MD :$cCenter for Drug Evaluation and Research,$d[1994]
215   $a1 electronic resource (ii, 30 pages)
300   $a"CMC 3."
300   $a"November 1994."
320   $aIncludes bibliographical references (page 29).
517   $aReviewer guidance 
606   $aDrugs$xAnalysis$xGovernment policy$zUnited States
606   $aChromatographic analysis$zUnited States
615  0$aDrugs$xAnalysis$xGovernment policy
615  0$aChromatographic analysis
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697097003321
996   $aReviewer guidance$93514523
997   $aUNINA